Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Pulse Biosciences (PLSE) Other Operating Expenses (2020 - 2025)

Pulse Biosciences has reported Other Operating Expenses over the past 4 years, most recently at $279000.0 for Q3 2025.

  • Quarterly results put Other Operating Expenses at $279000.0 for Q3 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $279000.0 (changed N/A YoY), and the annual figure for FY2022 was $24.0 million, up 43.33%.
  • Other Operating Expenses for Q3 2025 was $279000.0 at Pulse Biosciences, down from $2.1 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for PLSE hit a ceiling of $12.9 million in Q1 2021 and a floor of $279000.0 in Q3 2025.
  • Median Other Operating Expenses over the past 3 years was $5.0 million (2022), compared with a mean of $5.5 million.
  • Biggest five-year swings in Other Operating Expenses: soared 661.59% in 2021 and later plummeted 61.11% in 2022.
  • Pulse Biosciences' Other Operating Expenses stood at $5.3 million in 2021, then plummeted by 61.11% to $2.1 million in 2022, then crashed by 86.45% to $279000.0 in 2025.
  • The last three reported values for Other Operating Expenses were $279000.0 (Q3 2025), $2.1 million (Q4 2022), and $10.4 million (Q3 2022) per Business Quant data.